With the analysis among 60,232 patents, we discovered top 487 key players by total patent application. F. Hoffmann-La Roche Ltd., BASF AB, Janssen Pharmaceutica NV are dominant in this area. They take 8.05% of the total patent filing.
F. Hoffmann-La Roche Ltd.
Antwerpen, Belgium
Patent: 1,318
Nordrhein-Westfalen, Germany
Patent: 1,266
Basel-Stadt, Switzerland
Patent: 1,228
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 960
New York, United States
Patent: 752
Pennsylvania, United States
Patent: 641
Hessen, Germany
Patent: 607
New York, United States
Patent: 586
With the analysis among 452 patents, we discovered top 63 start-ups by total patent application. SyntheX, Inc., Institut National de la Santé et de la Recherche Médicale, BenevolentAI Bio Ltd. are active in this area.
California, United States
Patent: 111
Institut National de la Santé et de la Recherche Médicale
Rivus Pharmaceuticals, Inc.
Virginia, United States
Patent: 28
Biosplice Therapeutics, Inc.
California, United States
Patent: 23
NeuroCycle Therapeutics, Inc.
Massachusetts, United States
Patent: 22
ZURICH, Switzerland
Patent: 18
Bretagne, France
Patent: 16
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 13
Endogena Therapeutics, Inc.
California, United States
Patent: 10
With the analysis among related 13,986 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Incyte Corp., Bayer AG, F. Hoffmann-La Roche Ltd. take 4.07% of patent filing during this period.
Delaware, United States
Patent: 203
Nordrhein-Westfalen, Germany
Patent: 200
F. Hoffmann-La Roche Ltd.
Zhejiang University of Technology
Zhejiang Sheng, China
Patent: 105
Antwerpen, Belgium
Patent: 96
New York, United States
Patent: 94
Berlin, Germany
Patent: 82
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 81
South China University of Technology
Guangdong Sheng, China
Patent: 78
With the analysis among related 13,986 patents in last 5 years, we discover 113 new entrants. Vicore Pharma AB, BenevolentAI Bio Ltd., United Phosphorus, Inc. are the most active new entrants in this area.
Pennsylvania, United States
Patent: 35
Innate Tumor Immunity, Inc.
New York, United States
Patent: 32
Basel-Stadt, Switzerland
Patent: 29
Rivus Pharmaceuticals, Inc.
Virginia, United States
Patent: 28
NeuroCycle Therapeutics, Inc.
Massachusetts, United States
Patent: 22
First Bio Therapeutics Co. Ltd.
Changzhou Zhengjie Intelligent Manufacturing Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 21
Magenta Therapeutics, Inc.
Massachusetts, United States
Patent: 19
With the analysis among 8,932 patents, we discovered top 357 universities and scientific research institutions by total patent application. Zhejiang University of Technology, South China University of Technology, Zhejiang University are dominant in this area. They take 4.18% of the total patent filing.
Zhejiang University of Technology
Zhejiang Sheng, China
Patent: 139
South China University of Technology
Guangdong Sheng, China
Patent: 120
Zhejiang Sheng, China
Patent: 104
Jiangsu Sheng, China
Patent: 79
Tianjin Shi, China
Patent: 73
Dalian Institute of Chemical Physics Chinese Academy of Sciences
Liaoning Sheng, China
Patent: 70
Guilin University of Technology
Guangxi Zhuangzu Zizhiqu, China
Patent: 66
Shaanxi University of Science & Technology
Shaanxi Sheng, China
Patent: 65
Capital University of Medical Sciences
Beijing Shi, China
Patent: 62
Council of Scientific & Industrial Research